Development of a quantitative assay for hepatic HBV ccc DNA levels in patients with chronic hepatitis B
โ Scribed by Bettina Werle; Karsten Wursthorn; Jorg Petersen; Scott Bowden; Stephen Locarnini; Craig James; Carol Brosgart; Shelly Xiong; William Delaney; Craig Gibbs; Fabien Zoulim
- Book ID
- 118564922
- Publisher
- Elsevier Science
- Year
- 2002
- Tongue
- English
- Weight
- 139 KB
- Volume
- 36
- Category
- Article
- ISSN
- 0168-8278
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Selection of HBsAg-positive patients for antiviral therapy requires an estimation of disease activity and viral replication. Serum transaminases and histological analysis are commonly used t o as-
No data are available about the amount of hepatitis B virus (HBV) genomes in liver of patients with chronic HBV infection. The aim of this study was to quantify the intrahepatic HBV DNA in hepatitis B surface antigen (HBsAg)-positive patients with either active or suppressed viral replication and in
Low-level viremia due to hepatitis B virus (HBV) was demonstrated in the sera of two patients diagnosed previously as having non-B, non-C chronic hepatitis. Both patients had a "silent" HBV infection, because they were negative for both hepatitis B surface antigen (HBsAg) and anti-hepatitis B core a